IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $672,453 | -31.0% | 397,901 | +13.5% | 0.00% | – |
| Q2 2023 | $974,799 | -6.7% | 350,647 | -38.9% | 0.00% | – |
| Q1 2023 | $1,044,254 | -62.1% | 573,766 | +5.4% | 0.00% | – |
| Q4 2022 | $2,758,881 | -13.5% | 544,158 | -15.2% | 0.00% | – |
| Q3 2022 | $3,190,000 | -12.4% | 641,813 | -34.4% | 0.00% | – |
| Q2 2022 | $3,641,000 | -39.5% | 978,643 | -8.8% | 0.00% | -100.0% |
| Q1 2022 | $6,023,000 | +128.8% | 1,073,519 | +148.0% | 0.00% | – |
| Q4 2021 | $2,632,000 | -45.7% | 432,824 | -13.0% | 0.00% | -100.0% |
| Q3 2021 | $4,849,000 | -30.5% | 497,724 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $6,973,000 | -11.8% | 488,290 | +46.6% | 0.00% | 0.0% |
| Q1 2021 | $7,907,000 | – | 333,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |